Surgery Partners, Inc. Financial Ratios
SGRY / Health Care|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.31 (distress zone, below 1.8 threshold)
- Negative profit margin: -14.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
-9.4%
Profit Margin
-
Net Income / Revenue
Asset Turnover
-
Revenue / Total Assets
Equity Multiplier
4.41
Total Assets / Equity
Profitability
Gross Margin
-
Operating Margin
-
EBITDA
$119.1M
EBITDA Margin
-
Liquidity
Current Ratio
1.79
Quick Ratio
1.65
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
-
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2024 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-6.3%
-1.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.